WEGO Corporate and Strategy Overview
Platform-based development
new business initiatives (cont')
40
Endoscopy
Rehabilitation
Safe automatic drug
administration system
•
•
Leveraging partnership with
external experts and integration
with external team, WEGO
incorporated the cutting-edge
technologies and achieved
breakthroughs in core technology
development
In 2024, the Company is expecting
to launch, amongst others,
disposable ureteroscopes,
cystoscopes, endoscopes, 4K
image processing systems
The products set to launch in 2025
include disposable bronchoscopes,
hysteroscopes, 4K/8K fluorescence
endoscopes and related supporting
products, confocal endoscopes,
narrow-band imaging products and
respiratory iterative products
•
There is enormous potential for growth in the
demand for rehabilitation medical services with
supports from the government
By 2022, WEGO has entered the market
centered around precision rehabilitation.
WEGO introduced a brain-machine interface
rehabilitation training system, which has
qualified as the first medical device
registration certificate in China and has been
the first device enrolled into the promotion list
for key medical equipment by Ministry of
Industry and Information Technology
Highly recognized by multiple national
authorities and they have added "brain-
machine interface rehabilitation training" to
procurement catalogs as an innovative
technology
Introduced various intelligent and digitized
products including joint rehabilitation robots for
sports rehabilitation treatment, cognitive
impairment rehabilitation assessment and
training system
•
Developed various drug
administration system products
including automatic injection pens,
disposable multi-dose injection
pens, repeatable pen-style
injectors, and electronic intelligent
pens
Committing to enhance patient
safety for family medicine and to
improve compliance with WEGO's
product solutions
WEGO威高
9View entire presentation